Publications by authors named "Niloufar Gharavi"
Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial.
Saeed Erfanpoor Seyed Reza Banihashemi Ladan Mokhbaeralsafa Saeed Kalantari Ali Es-Haghi Niloufar Gharavi
BMC Med
February 2024
Article Synopsis
- Booster vaccinations are essential to enhance and sustain immunity against COVID-19, especially against new variants, and the study focused on the Razi Cov Pars (RCP) vaccine as a booster for individuals previously vaccinated with the BBIBP-CorV vaccine.
- The clinical trial involved 483 adults, examining the safety and immune response to RCP compared to BBIBP-CorV by measuring neutralizing antibody levels and specific IgG antibodies over time.
- Results showed that RCP significantly boosted neutralizing antibodies, increasing them approximately 21 times higher than baseline, and provided a favorable safety profile for participants.